|
|
||||||||
a Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, Tochigi, Japan;
b Department of Cell Differentiation, Institute of Molecular Genetics and Embryology, Kumamoto University School of Medicine, Kumamoto, Japan;
c Department of Hematology, Jichi Medical School, Tochigi, Japan
Key Words. Gene therapy • Green fluorescent protein • Hematopoietic progenitor • Retrovirus vector • Selectable marker • Flow cytometry
Dr. Akihiro Kume, Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan.
Recombinant retroviruses are most commonly used in hematopoietic
stem cell gene therapy trials, but gene transfer efficiency is still
inadequate with the present vectors. One approach for overcoming this
problem is to develop methods of selecting and enriching the
successfully transduced cells. We investigated the feasibility of
using the green fluorescent protein (GFP) gene as a selectable marker
of hematopoietic cells. When M1 murine leukemia cells were
electroporated with GFP expression vectors, a red-shifted mutant
(S65T) GFP showed several-fold greater fluorescence than the wild-type
GFP and generated readily detectable green light under control of SRa
or CAG promoter. We then inserted an SRa-S65T GFP cassette into the
MSCV retrovirus vector and established virus producer cells. Infection
of primary murine bone marrow cells resulted in a distinct population
with green fluorescence, which was separated by fluorescence-activated
cell sorting. The fractionated bright cells gave rise to fluorescent
spleen colonies in lethally irradiated mice, while the
fluorescence-negative cells yielded only dark colonies. These results
indicated that GFP is a faithful marker in gene transfer into
hematopoietic progenitor/stem cells, facilitating selection of the
transduced cells and tracking of their progeny in vivo. Stem
Cells 1999;17:226-232
This article has been cited by other articles:
![]() |
J.-C. Tseng, B. Levin, T. Hirano, H. Yee, C. Pampeno, and D. Meruelo In Vivo Antitumor Activity of Sindbis Viral Vectors J Natl Cancer Inst, December 4, 2002; 94(23): 1790 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arima, H. Toyama, H. Ichii, S. Kojima, S. Okada, M. Hatano, G. Cheng, M. Kubo, T. Fukuda, and T. Tokuhisa A Putative Silencer Element in the IL-5 Gene Recognized by Bcl6 J. Immunol., July 15, 2002; 169(2): 829 - 836. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |